TissueScan, Colon Cancer cDNA Array II

SKU
HCRT302
TissueScan Colon Cancer Tissue qPCR Panel II (5) containing five identical sets of 48 tissues covering four disease stages and normal tissues
  $1,870.00
In Stock*
Specifications
Specifications
Product Data
TissueScan Type Cancer Specific
Array Name Colon Cancer cDNA Array II
Clinical Info
Diagnosis Category Colon Cancer
Tissue Colon
Shipping Ambient
Description TissueScan Colon Cancer Tissue qPCR Panel II (5) containing five identical sets of 48 tissues covering four disease stages and normal tissues
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

P2X7 a new therapeutic target to block vesicle-dependent metastasis in colon carcinoma: Role of the A2A/CD39/CD73 axis
Pegoraro, De Marchi, Ruo et al
Cell Death Dis (2025) 16 (1), 587 DOI: 10.1038/s41419-025-07897-2
Cited by 17
Snippet: …Immunohistochemistry demons;Samples from human colon carcinoma patients were obtained from five commercial arrays (TissueScan cDNA arrays HCRT301, HCRT302, HCRT303, HCRT304, HCRT305, OriGene, Rockville, Maryland, USA)
FigureFigureFigure
P2X7 a new therapeutic target to block vesicle-dependent metastasis in colon carcinoma: role of the A2A/CD39/CD73 axis
Adinolfi, Pegoraro, De Marchi et al
Research Square (2024)
Snippet: Samples from human colon carcinoma patients were obtained from ve commercial arrays (TissueScan cDNA arrays HCRT301, HCRT302, HCRT303, HCRT304, HCRT305, OriGene, Rockville, Maryland, USA). Samples in which mRNA levels for housekeeping genes were not detectable were excluded from the analysis. A total of 158 patients were analyzed and subdivided according to the
Cathepsin V Mediates the Tazarotene-induced Gene 1-induced Reduction in Invasion in Colorectal Cancer Cells
Wang, Wang, Wu et al
Cell Biochem. Biophys. (2020)
Cited by 28
AI Summary: OriGene contributed a colorectal cancer cDNA array (containing five normal colon tissue samples and 43 adenocarcinoma colon samples) to this study, enabling the authors to analyze gene expression differences related to TIG1 and cathepsin V in colorectal cancer.
Snippet: each sample. Alternatively, a colorectal cancer cDNA array containing five normal colon tissue samples and 43 adenocarcinoma colon samples was purchased from OriGene Technologies (Rockville, MD, USA). After quantitative
Showing 1-3 of 3 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products